Cargando…

Palmitic acid causes increased dihydroceramide levels when desaturase expression is directly silenced or indirectly lowered by silencing AdipoR2

BACKGROUND: AdipoR1 and AdipoR2 (AdipoRs) are plasma membrane proteins often considered to act as adiponectin receptors with a ceramidase activity. Additionally, the AdipoRs and their yeast and C. elegans orthologs are emerging as membrane homeostasis regulators that counter membrane rigidification...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz, Mario, Henricsson, Marcus, Borén, Jan, Pilon, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627610/
https://www.ncbi.nlm.nih.gov/pubmed/34839823
http://dx.doi.org/10.1186/s12944-021-01600-y
_version_ 1784606868443758592
author Ruiz, Mario
Henricsson, Marcus
Borén, Jan
Pilon, Marc
author_facet Ruiz, Mario
Henricsson, Marcus
Borén, Jan
Pilon, Marc
author_sort Ruiz, Mario
collection PubMed
description BACKGROUND: AdipoR1 and AdipoR2 (AdipoRs) are plasma membrane proteins often considered to act as adiponectin receptors with a ceramidase activity. Additionally, the AdipoRs and their yeast and C. elegans orthologs are emerging as membrane homeostasis regulators that counter membrane rigidification by promoting fatty acid desaturation and incorporation of unsaturated fatty acids into phospholipids, thus restoring fluidity. METHODS: Using cultured cells, the effects of AdipoR silencing or over-expression on the levels and composition of several sphingolipid classes were examined. RESULTS: AdipoR2 silencing in the presence of exogenous palmitic acid potently causes increased levels of dihydroceramides, a ceramide precursor in the de novo ceramide synthesis pathway. Conversely, AdipoR2 over-expression caused a depletion of dihydroceramides. CONCLUSIONS: The results are consistent with AdipoR2 silencing leading to increased intracellular supply of palmitic acid that in turn leads to increased dihydroceramide synthesis via the rate-limiting serine palmitoyl transferase step. In agreement with this model, inhibiting the desaturase SCD or SREBF1/2 (positive regulators of SCD) also causes a strong increase in dihydroceramide levels. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-021-01600-y.
format Online
Article
Text
id pubmed-8627610
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86276102021-11-30 Palmitic acid causes increased dihydroceramide levels when desaturase expression is directly silenced or indirectly lowered by silencing AdipoR2 Ruiz, Mario Henricsson, Marcus Borén, Jan Pilon, Marc Lipids Health Dis Research BACKGROUND: AdipoR1 and AdipoR2 (AdipoRs) are plasma membrane proteins often considered to act as adiponectin receptors with a ceramidase activity. Additionally, the AdipoRs and their yeast and C. elegans orthologs are emerging as membrane homeostasis regulators that counter membrane rigidification by promoting fatty acid desaturation and incorporation of unsaturated fatty acids into phospholipids, thus restoring fluidity. METHODS: Using cultured cells, the effects of AdipoR silencing or over-expression on the levels and composition of several sphingolipid classes were examined. RESULTS: AdipoR2 silencing in the presence of exogenous palmitic acid potently causes increased levels of dihydroceramides, a ceramide precursor in the de novo ceramide synthesis pathway. Conversely, AdipoR2 over-expression caused a depletion of dihydroceramides. CONCLUSIONS: The results are consistent with AdipoR2 silencing leading to increased intracellular supply of palmitic acid that in turn leads to increased dihydroceramide synthesis via the rate-limiting serine palmitoyl transferase step. In agreement with this model, inhibiting the desaturase SCD or SREBF1/2 (positive regulators of SCD) also causes a strong increase in dihydroceramide levels. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-021-01600-y. BioMed Central 2021-11-28 /pmc/articles/PMC8627610/ /pubmed/34839823 http://dx.doi.org/10.1186/s12944-021-01600-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ruiz, Mario
Henricsson, Marcus
Borén, Jan
Pilon, Marc
Palmitic acid causes increased dihydroceramide levels when desaturase expression is directly silenced or indirectly lowered by silencing AdipoR2
title Palmitic acid causes increased dihydroceramide levels when desaturase expression is directly silenced or indirectly lowered by silencing AdipoR2
title_full Palmitic acid causes increased dihydroceramide levels when desaturase expression is directly silenced or indirectly lowered by silencing AdipoR2
title_fullStr Palmitic acid causes increased dihydroceramide levels when desaturase expression is directly silenced or indirectly lowered by silencing AdipoR2
title_full_unstemmed Palmitic acid causes increased dihydroceramide levels when desaturase expression is directly silenced or indirectly lowered by silencing AdipoR2
title_short Palmitic acid causes increased dihydroceramide levels when desaturase expression is directly silenced or indirectly lowered by silencing AdipoR2
title_sort palmitic acid causes increased dihydroceramide levels when desaturase expression is directly silenced or indirectly lowered by silencing adipor2
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627610/
https://www.ncbi.nlm.nih.gov/pubmed/34839823
http://dx.doi.org/10.1186/s12944-021-01600-y
work_keys_str_mv AT ruizmario palmiticacidcausesincreaseddihydroceramidelevelswhendesaturaseexpressionisdirectlysilencedorindirectlyloweredbysilencingadipor2
AT henricssonmarcus palmiticacidcausesincreaseddihydroceramidelevelswhendesaturaseexpressionisdirectlysilencedorindirectlyloweredbysilencingadipor2
AT borenjan palmiticacidcausesincreaseddihydroceramidelevelswhendesaturaseexpressionisdirectlysilencedorindirectlyloweredbysilencingadipor2
AT pilonmarc palmiticacidcausesincreaseddihydroceramidelevelswhendesaturaseexpressionisdirectlysilencedorindirectlyloweredbysilencingadipor2